70594-080-02 : NDC 2025 Code

70594-080-02 : Piperacillin Sodium And Tazobactam Sodium ( Piperacillin Sodium And Tazobactam Sodium )

Additionally :

You can get information about “70594-080-02” NDC code in 70594-080-02 in HTML format

HTML | 70594-080-02 in TXT (Plain Text) format

TXT | 70594-080-02 in PDF (Portable Document Format)

PDF | 70594-080-02 in XML format

XML formats.

NDC Code : 70594-080-02 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "70594-080-02",
    "PackageDescription": "10 VIAL in 1 CARTON (70594-080-02)  / 150 mL in 1 VIAL (70594-080-01) ",
    "NDC11Code": "70594-0080-02",
    "ProductNDC": "70594-080",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Piperacillin Sodium And Tazobactam Sodium",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Piperacillin Sodium And Tazobactam Sodium",
    "DosageFormName": "INJECTION, POWDER, FOR SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20210110",
    "EndMarketingDate": "20251231",
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA212287",
    "LabelerName": "Xellia Pharmaceuticals USA LLC",
    "SubstanceName": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
    "StrengthNumber": "4; 500",
    "StrengthUnit": "g/150mL; mg/150mL",
    "Pharm_Classes": "Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2024-12-12",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": null,
    "StartMarketingDatePackage": "20210110",
    "EndMarketingDatePackage": "20251231",
    "SamplePackage": "N"
  }
}